At Work With: Dave Mihalovic

At Work With  . . . Dave Mihalovic
At Work With . . . Dave Mihalovic

Dave Mihalovic

EVP, experience and innovation, Evoke Health


Q: What was your biggest break?

My most valuable break dates back to the early dot-com days. To make a long story short, Richard Branson signed my friends and me to release a product, which led to instant credibility and recognition.

 Q: What's the best or worst part of your job?

When you love what you do, it's hard to say there are any bad parts. The thing that frustrates me most is when a great opportunity backed by a great idea falls apart in execution. 

Q: How long is a typical meeting with clients?

I may meet with marketing teams, IT teams or regulatory teams and on average meetings last a couple hours—but can last a day. 

Q: Did college prepare you for your career?

I went to Rutgers and Par-sons for grad school. I studied not only advertising but also design technology, so yeah, it set me up perfectly. 

Q: What would the title of your book be?

One Wild Ride: Why a Career in Advertising Is Just Like Riding a Harley Cross-Country. Why? Because they're both unpredictably exhilarating.

Opinion

How to Shatter the Glass Ceiling

How Pharma Can Benefit from the Transformation of Pharmacy

Newsletters

Live at MM&M Transforming Healthcare

Pharma faces its 'oh, shit' moment

In his keynote address at the MM&M Transforming Healthcare conference, Dr. Gautam Gulati says the industry is being outpaced by its innovation.

Merck, Takeda execs: Is AI the new bad app?

One executive referred to AI as a "black box" and as the "Tower of Babel."

Value-based care requires innovators to challenge the status quo

Execs stressed the importance of collaboration, consumer-mindedness.

Admetsys wins the 2017 MM&M Startup Showdown

The artificial pancreas can provide value to the health system.

Top 40 Healthcare Transformers

MM&M honors 40 upstarts and veteran innovation gurus.

Top 10 Innovation Catalysts

For the first time MM&M honors a group of 10 agency execs.